SCHEMBL7991672

SCHEMBL7991672

O=c1[nH]c(-c2ccncc2)nc2ncn(CCc3ccccc3)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.46
ALDH1A1 P00352 4/20 0.45
HPGD P15428 2/20 0.45
MAPT P10636 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
GRIA1 P42261 3/20 0.44
GRIA2 P42262 3/20 0.44
GRIA3 P42263 3/20 0.44
GRIA4 P48058 3/20 0.44
KMT2A Q03164 1/20 0.43
GSK3B P49841 1/20 0.40
PDE5A O76074 1/20 0.40
PRMT5 O14744 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991648 0.93 KDM4E (0.54) CNOT7ALDH1A1HPGDMAPTALOX15
SCHEMBL7974613 0.93 CNOT7 (0.49) CNOT7ALDH1A1HPGDKDM4ELMNA
SCHEMBL7974445 0.88 ALDH1A1 (0.56) CNOT7ALDH1A1HPGDMAPTALOX15
SCHEMBL7986324 0.88 HPGD (0.48) CNOT7ALDH1A1HPGDMAPTKDM4E
SCHEMBL7973869 0.88 TNKS (0.46) CNOT7ALDH1A1HPGDKDM4ELMNA
SCHEMBL7984240 0.86 LMNA (0.58) CNOT7ALDH1A1HPGDKDM4ELMNA
SCHEMBL7985285 0.84 ALDH1A1 (0.47) CNOT7ALDH1A1HPGDMAPTKDM4E
SCHEMBL7984680 0.83 CNOT7 (0.43) CNOT7ALDH1A1HPGDKDM4ELMNA
SCHEMBL7984403 0.83 CNOT7 (0.47) CNOT7ALDH1A1HPGDKDM4ELMNA
SCHEMBL7988550 0.83 ALDH1A1 (0.44) CNOT7ALDH1A1HPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed